Archives for April 2008
Cancer Researchers See the Light: Caliper Life Sciences Intruduces Bioware Ultra
Five cancer cells were injected subcutaneously into the dorsal region near the thigh of mouse. Tumor growth is monitored weekly by an IVIS Spectrum. The tumor was visible 28 days post implantation; Bioluminescent signal could be detected in the animal long before it could be measured with a caliper.
By tagging a tumor with the gene […]
Natus Further Consolidates U.S. Newborn Hearing Loss Screening Market with SonaMed Acquisition
Natus Medical announced yesterday that it will acquire SonaMed, a privately held company based in Waltham, MA.
SonaMed manufactures and markets the Clarity Screener for the screening of hearing loss in newborns. The company reported revenues of $3.5 million in 2007.
According to Jim Hawkins, Natus’ President and CEO, “SonaMed has successfully created a distinct presence in […]
InSound Medical’s Lyric: A Long Time Coming
The New York Times offered high praise today to hearing aid developed by Newark, CA-based InSound Medical.
The device, Lyric, is placed completely within the ear canal by a physician during a three-minute, non-surgical procedure requiring no anesthesia.
Lyric was cleared by the FDA in 2002 (it was then dubbed the XT), though InSound waited until 2007 […]
AngioDynamics Offers to Purchase Diomed Assets
AngioDynamics and Diomed, who once sat on opposing sides of the courtroom, have found occasion to work together, though only after Diomed filed for bankruptcy.
Angiodynamics has agreed to pay $8 million in cash for Diomed’s U.S. business engaged in the sale of endovenous laser systems for the treatment of varicose veins. In addition, AngioDynamics has […]
AdvaMed 2008 Now Accepting Applications for Company Presentations
Medical technology and device companies interested in raising capital, partnering products or initiating strategic alliances are encouraged to apply for a presentation slot at AdvaMed 2008. The application deadline is June 20th, 2008.
Open to companies at all stages of development, presentation applications will be competitively evaluated and selected by a committee of industry leaders and […]
Vascular Solutions Settles with Diomed for $3.5 Million
Diomed has fought literally to the death in defense of its “777 Patent” covering the endovascular laser treatment of varicose veins. In March, the company filed for bankruptcy, smothered by legal issues which turned the device manufacturer into little more than a law firm.
Diomed will sell some of its assets to a German medical laser […]
St. Jude Medical to Acquire EP MedSystems
In a deal finalized this morning, St. Jude Medical will acquire EP MedSystems (EPMD) for $92.1 million in cash and stock. The deal values EPMD at $3.00 per share, a huge premium over yesterday’s closing price of $1.41.
In 2007, EPMD recorded record annual revenues of $18.9 million, an increase of 21% year-over-year.
EPMD’s EP-WorkMate is a […]
Obese Patients Create New Transportation Opportunities
Nearly 40 million U.S. adults are classified as obese. Of these, it is estimated that four million are severely obese and 1.5 million are morbidly obese (BMI > 40).
A number of medical conditions have been associated with obesity – osteoarthritis, sleep apnea, diabetes, cancer, cardiovascular disease – to name a few. The annual health care […]
Nanogen Strengthens Active Partnering and Licensing Program
Nanogen and Thermo Fisher Scientific Partner to Provide Molecular Biology Products to the Research Market
As the biomedical industry works to gain a better understanding of the molecular basis of disease, the need for specific methods to detect genetic variation are becoming increasingly central to research.
San Diego, CA-based Nanogen has developed a suite of molecular genetics […]
Aethlon Seeks to Reinforce Hemopurifier’s Broad-Spectrum Utility with West Nile Studies
Aethlon Medical’s Hemopurifier has been shown to capture or inhibit the growth of other envelope viruses including HIV, SIV, FIV, Hepatitis C, Measles, Mumps, Influenza, Ebola, Marburg, and Orthopox viruses. Researchers have also documented the Hemopurifier’s ability to reverse immune suppression in cancer patients.
The company announced Wednesday that it will initiate studies to test the […]
